The problem of cardiovascular risk stratification depending on the severity of carotid and femoral artery atherosclerosis
https://doi.org/10.15829/1728-8800-2020-2441
Abstract
Currently, the concept of atherosclerosis has undergone a number of changes. On the one hand, carotid atherosclerosis, like femoral, is a disease that must be treated directly, and on the other hand, it is a modifier of cardiovascular risk. This review is devoted to aspects of cardiovascular risk stratification depending on the severity and progression of carotid and femoral artery atherosclerosis.
About the Authors
A. I. Ershova
National Medical Research Center for Therapy and Preventive Medicine.
Russian Federation
Russian Federation
Moscow
T. V. Balakhonova
National Medical Research Center of Cardiology.
Russian Federation
Russian Federation
Moscow
A. A. Ivanova
I.M. Sechenov First Moscow State Medical University
Russian Federation
Russian Federation
Moscow
A. N. Meshkov
National Medical Research Center for Therapy and Preventive Medicine
Russian Federation
Russian Federation
Moscow
S. A. Boytsov
National Medical Research Center of Cardiology
Russian Federation
Russian Federation
Moscow
O. M. Drapkina
National Medical Research Center for Therapy and Preventive Medicine
Russian Federation
Russian Federation
Moscow
References
1. 37 Spence JD, Eliasziw M, DiCicco M, et al. Carotid plaque area: a tool for targeting and evaluating vascular preventive therapy. Stroke. 2002;33( 12):2916-22. doi: 10.1161/01.str.000004220716156.b9.
2. Diagnostics and correction of lipid metabolism disorders in order to prevent and treat atherosclerosis. Russian recommendations VI revision. Atherosclerosis and dyslipidemias. 2017;3(28):5-23. (In Russ.)
3. Boulos NM, Gardin JM, Malik S, et al. Carotid Plaque Characterization, Stenosis, and Intima-Media Thickness According to Age and Gender in a Large Registry Cohort. Am J Cardiol. 2016; 117(7): 1185-91. doi:101016/j.amjcard.2015.12.062.
4. Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS). Eur Heart J. 2019 Aug 31. pii: ehz455. doi:10.1093/eurheartj/ehz455.
5. Den Ruijter HM, Peters SA, Anderson TJ, et al. Common carotid intima-media thickness measurements in cardiovascular risk prediction: a meta-analysis. JAMA. 2012; 308( 8): 796-803. doi: 10.1001/jama.2012.9630.
6. Polonsky TS, Greenland P. CVD screening in low-risk, asymptomatic 7. adults: clinical trials needed. Nat Rev Cardiol. 2012;9(10):599-604. doi:10.1038/nrcardio.2012.114.
7. Ezhov MV, Sergienko IV, Rozhkova TA, et al. Diagnosis and treatment of family hypercholesterolemia (russian guidelines). The Bulletin of Contemporary Clinical Medicine. 2017; 10(2):72-9. (In Russ.) doi:10.20969/VSKM.201710(2).72-79.
8. Piepoli MF, Hoes AW, Agewall S, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth 8. Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association 9. for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J. 2016;37(29):2315-81. doi:10.1093/eurheartj/ehw106.
9. . Spence JD, Hackam DG. Treating arteries instead of risk factors: a paradigm change in management of atherosclerosis. Stroke. 2010;41(6):1193-9. doi:10.1161/STROKEAHA.110.577973.
10. Aboyans V, Ricco JB, Bartelink MEL, et al. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries Endorsed by: the European Stroke Organization (ESO) The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J. 2018;39(9):763-816. doi :10.1093/eurheartj/ehx095.
11. Brinjikji W, Rabinstein AA, Lanzino G, et al. Ultrasound Characteristics of Symptomatic Carotid Plaques: A Systematic Review and Meta-Analysis. Cerebrovasc Dis. 2015;40(3-4): 165-74. doi:10.1159/000437339.
12. de Weerd M, Greving JP, de Jong AW, et al. Prevalence of asymptomatic carotid artery stenosis according to age and sex: systematic review and metaregression analysis. Stroke. 2009;40(4): 1105-13. doi:10.1161/STROKEAHA.108.532218.
13. Ershova AI, Meshkov AN, Deev AD, et al. Atherosclerotic plaque in carotid arteries as a risk marker for cardiovascular events risk in middle aged population. Cardiovascular Therapy and Prevention. 2018;17(4):34-9. (In Russ.) doi:10.15829/1728-8800-2018-4-34-39.
14. Postley JE, Luo Y, Wong ND, et al. Identification by ultrasound evaluation of the carotid and femoral arteries of high-risk subjects missed by three validated cardiovascular disease risk algorithms. Am J Cardiol. 2015;116(10):1617-23. doi:10.1016/j.amjcard.2015.08.031.
15. Gepner AD, Young R, Delaney JA, et al. Comparison of coronary artery calcium presence, carotid plaque presence, and carotid intima-media thickness for cardiovascular disease prediction in the Multi-Ethnic Study of Atherosclerosis. Circ Cardiovasc Imaging. 2015;8( 1). pii: e002262. doi: 10.1161/CIRCIMAGING.114.002262.
16. Nambi V, Chambless L, Folsom AR, et al. Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk: the ARIC (Atherosclerosis Risk In Communities) study. J Am Coll Cardiol. 2010;55( 15): 1600-7 doi:10.1016/j.jacc.2009.11.075.
17. Polak JF, Pencina MJ, Pencina KM, et al. Carotid-wall intima-media thickness and cardiovascular events. N Engl J Med. 2011; 365(3):213-21. doi:10.1056/NEJMoa1012592.
18. Baber U, Mehran R, Sartori S, et al. Prevalence, impact, and predictive value of detecting subclinical coronary and carotid atherosclerosis in asymptomatic adults: the BioImage study. J Am Coll Cardiol. 2015;65:1065-74. doi: 10.1016/j.jacc.2015.01.017.
19. Peters SA, den Ruijter HM, Bots ML, et al. Improvements in risk stratification for the occurrence of cardiovascular disease by imaging subclinical atherosclerosis: a systematic review. Heart. 2012;98(3):177-84. doi:10.1136/heartjnl-2011-300747.
20. Zhang Y, Fang X, Hua Y, et al. Carotid Artery Plaques, Carotid Intima-Media Thickness, and Risk of Cardiovascular Events and All-Cause Death in Older Adults: A 5-Year Prospective, Community-Based Study. Angiology. 2018; 69( 2): 120-9. doi:10.1177/0003319717716842.
21. 17 Inaba Y, Chen JA, Bergmann SR. Carotid plaque, compared with carotid intima-media thickness, more accurately predicts coronary artery disease events: a meta-analysis. Atherosclerosis. 2012;220(1): 128-33. doi: 10.1016/j.atherosclerosis.2011.06.044.
22. Sehestedt T, Jeppesen J, Hansen TW, et al. Risk prediction is improved by adding markers of subclinical organ damage to SCORE. Eur Heart J. 2010;31(7):883-91. doi:10.1093/eurheartj/ehp546.
23. Yerly P, Rodondi N, Viswanathan B, et al. Association between conventional risk factors and different ultrasound-based markers of atherosclerosis at carotid and femoral levels in a middle-aged population. Int J Cardiovasc Imaging. 2013;29(3):589-99. doi:10.1007/s10554-012-0124-3.
24. Laclaustra M, Casasnovas JA, Fernandez-Ortiz A, et al. Femoral and Carotid Subclinical Atherosclerosis Association With Risk Factors and Coronary Calcium: The AWHS Study. J Am Coll Cardiol. 2016; 67 (1 1): 1263-74. doi: 10.1016/j.jacc.2015.12.056.
25. Held C, Hjemdahl P, Eriksson SV, et al. Prognostic implications of intima-media thickness and plaques in the carotid and femoral arteries in patients with stable angina pectoris. Eur Heart J. 2001;22(1):62-72. doi:10.1053/euhj.1999.2006.
26. Colledanchise KN, Mantella LE, Bullen M, et al. Combined Femoral and Carotid Plaque Burden Identifies Obstructive Coronary Artery Disease in Women. J Am Soc Echocardiogr. 2019 Oct 10. pii: S0894-7317(19)3091 1-3. doi:10.1016/j.echo.2019.07024.
27. Meshkov AN, Ershova AI, Deev AD, et al. Distribution of lipid profile values in economically active men and women in Russian Federation results of the ESSE-RF study for the years 2012-2014. Cardiovascular Therapy and Prevention. 2017; 16(4):62-7 (In Russ.) doi:10.15829/1728-8800-2017-4-62-67
28. Byrne P, Cullinan J, Smith SM. Statins for primary prevention of cardiovascular disease. BMJ. 2019;367:l5674. doi:10.1136/bmj.l5674.
29. Milionis H, Ntaios G, Korompoki E, et al. Statin-based therapy for primary and secondary prevention of ischemic stroke: A meta-analysis and critical overview. Int J Stroke. 2019 Sep 7:1747493019873594. doi:10.1177/1747493019873594.
30. Sillesen H, Sartori S, Sandholt B, et al. Carotid plaque thickness and carotid plaque burden predict future cardiovascular events in asymptomatic adult Americans. Eur Heart J Cardiovasc Imaging. 2018;19:10421050. doi:10.1093/ehjci/jex239.
31. Polak JF, Szklo M, Kronmal RA, et al. The value of carotid artery plaque and intima-media thickness for incident cardiovascular disease: the multi-ethnic study of atherosclerosis. J Am Heart Assoc. 2013;2(2):e000087 doi:10.1161/JAHA.113.000087.
32. Berard E, Bongard V, Ruidavets JB, et al. Pulse wave velocity, pulse pressure and number of carotid or femoral plaques improve prediction of cardiovascular death in a population at low risk. J Hum Hypertens. 2013;27(9):529-34. doi: 10.1038/jhh.2013.8.
33. Plichart M, Celermajer DS, Zureik M, et al. Carotid intima-media thickness in plaque-free site, carotid plaques and coronary heart disease risk prediction in older adults. The Three-City Study. Atherosclerosis. 2011;219(2): 917-24. doi: 10.1016/j.atherosclerosis.201 1.09.024.
34. Johnsen SH, Mathiesen EB, Joakimsen O, et al. Carotid atherosclerosis is a stronger predictor of myocardial infarction in women than in men: a 6-year follow-up study of 6226 persons: the Tromse Study. Stroke. 2007;38(11):2873-80. doi:10.1161/STROKEAHA.107.487264.
35. Tada H, Nakagawa T, Okada H, et al. Clinical Impact of Carotid Plaque Score rather than Carotid Intima-Media Thickness on Recurrence of Atherosclerotic Cardiovascular Disease Events. J AtherosclerThromb. 2019 May 18. doi:10.5551/jat.49551.
36. Hirata T, Arai Y, Takayama M, et al. Carotid Plaque Score and Risk of Cardiovascular Mortality in the Oldest Old: Results from the TOOTH Study. J Atheroscler Thromb. 2018;25(1):55-64. doi:10.5551/jat.3791 1.
37. Kocyigit D, Gurses KM, Taydas O, et al. Role of femoral artery ultrasound imaging in cardiovascular event risk prediction in a primary prevention cohort at a medium-term follow-up. J Cardiol. 2019 Oct 16. pii: S0914-5087(19)30302-8. doi:10.1016/j.jjcc.2019.09.012.
38. Gupta A, Kesavabhotla K, Baradaran H, et al. Plaque echolucency and stroke risk in asymptomatic carotid stenosis: a systematic review and meta-analysis. Stroke. 2015;46( 1 ):91-7 doi: 10.1161/STROKEAHA.114.006091.
39. Sabeti S, Schlager O, Exner M, et al. Progression of carotid stenosis detected by duplex ultrasonography predicts adverse outcomes in cardiovascular high-risk patients. Stroke. 2007;38(1 1):2887-94. doi:101161/STROKEAHA.107488387
40. Bertges DJ, Muluk V, Whittle J, et al. Relevance of carotid stenosis progression as a predictor of ischemic neurological outcomes. Arch Intern Med. 2003;163(19):2285-9. doi:10.1001/archinte.163.19.2285.
41. 37 Spence JD, Eliasziw M, DiCicco M, et al. Carotid plaque area: a tool for targeting and evaluating vascular preventive therapy. Stroke. 2002;33( 12):2916-22. doi: 10.1161/01.str.000004220716156.b9.
42. Boulos NM, Gardin JM, Malik S, et al. Carotid Plaque Characterization, Stenosis, and Intima-Media Thickness According to Age and Gender in a Large Registry Cohort. Am J Cardiol. 2016; 117(7): 1185-91. doi:101016/j.amjcard.2015.12.062.
43. Den Ruijter HM, Peters SA, Anderson TJ, et al. Common carotid intima-media thickness measurements in cardiovascular risk prediction: a meta-analysis. JAMA. 2012; 308( 8): 796-803. doi: 10.1001/jama.2012.9630.
44. Ezhov MV, Sergienko IV, Rozhkova TA, et al. Diagnosis and treatment of family hypercholesterolemia (russian guidelines). The Bulletin of Contemporary Clinical Medicine. 2017; 10(2):72-9. (In Russ.) doi:10.20969/VSKM.201710(2).72-79.
Review
For citations:
Ershova A.I., Balakhonova T.V., Ivanova A.A., Meshkov A.N., Boytsov S.A., Drapkina O.M. The problem of cardiovascular risk stratification depending on the severity of carotid and femoral artery atherosclerosis. Cardiovascular Therapy and Prevention. 2020;19(2):2441. (In Russ.) https://doi.org/10.15829/1728-8800-2020-2441
Views:
859
Email this article 
